[Pharmacology of cobalt nitrosopentacyanoferrate 3].
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism / Q000494:pharmacology; D003035:Cobalt / Q000494:pharmacology* / Q000633:toxicity; D004285:Dogs; D005260:Female; D005295:Ferrocyanides / Q000494:pharmacology* / Q000633:toxicity; D006321:Heart / Q000187:drug effects*; D008297:Male; D051379:Mice; D009603:Nitroso Compounds / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012964:Sodium
D000959:Antihypertensive Agents; D002395:Catecholamines; D005295:Ferrocyanides; D009603:Nitroso Compounds; D003035:Cobalt; D012964:Sodium
Pharmacologie du nitrosopentacyanoferrate 3 de cobalt.